# InnovAge Holding Corp.: financial statements, quarterly

INNV · Nasdaq · CIK 1834376 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/innv.md) · [Financials](/companies/innv/financials.md) · [Filings](/companies/innv/filings.md) · [Insiders](/companies/innv/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/innv/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [182](/filings/0001834376-24-000086.md) | [189](/filings/0001834376-25-000003.md) | [193](/filings/0001834376-25-000010.md) | [199 d](/filings/0001834376-25-000062.md) | [205](/filings/0001834376-25-000074.md) | [209](/filings/0001834376-26-000013.md) | [218](/filings/0001834376-26-000022.md) | [221 d](/filings/0001834376-26-000049.md) | [236](/filings/0001834376-25-000074.md) | [240](/filings/0001834376-26-000013.md) | [252](/filings/0001834376-26-000022.md) | [262 d](/filings/0001834376-26-000049.md) |
| Gross profit | $m | [27.9](/filings/0001834376-24-000086.md) | [33.6](/filings/0001834376-25-000003.md) | [34.0](/filings/0001834376-25-000010.md) | [36.6 d](/filings/0001834376-25-000062.md) | [34.5](/filings/0001834376-25-000074.md) | [37.1](/filings/0001834376-26-000013.md) | [40.7](/filings/0001834376-26-000022.md) | [41.3 d](/filings/0001834376-26-000049.md) | [51.4](/filings/0001834376-25-000074.md) | [52.8](/filings/0001834376-26-000013.md) | [61.0](/filings/0001834376-26-000022.md) | [62.6 d](/filings/0001834376-26-000049.md) |
| Operating income | $m | [(10.7)](/filings/0001834376-24-000086.md) | [(1.8)](/filings/0001834376-25-000003.md) | [(5.8)](/filings/0001834376-25-000010.md) | [(4.9) d](/filings/0001834376-25-000062.md) | [(4.9)](/filings/0001834376-25-000074.md) | [(12.6)](/filings/0001834376-26-000013.md) | [(10.2)](/filings/0001834376-26-000022.md) | [(2.2) d](/filings/0001834376-26-000049.md) | [8.3](/filings/0001834376-25-000074.md) | [13.3](/filings/0001834376-26-000013.md) | [(29.1)](/filings/0001834376-26-000022.md) | [10.1 d](/filings/0001834376-26-000049.md) |
| Interest expense | $m | [0.7](/filings/0001834376-23-000027.md) | [0.9](/filings/0001834376-24-000008.md) | [1.0](/filings/0001834376-24-000022.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.2](/filings/0001834376-24-000086.md) | [0.1](/filings/0001834376-25-000003.md) | [(0.2)](/filings/0001834376-25-000010.md) | [1.3 d](/filings/0001834376-25-000062.md) | [0.4](/filings/0001834376-25-000074.md) | [0.0](/filings/0001834376-26-000013.md) | [0.1](/filings/0001834376-26-000022.md) | [0.8 d](/filings/0001834376-26-000049.md) | [0.2](/filings/0001834376-25-000074.md) | [0.7](/filings/0001834376-26-000013.md) | [0.2](/filings/0001834376-26-000022.md) | [(0.1) d](/filings/0001834376-26-000049.md) |
| Net income | $m | [(10.3)](/filings/0001834376-24-000086.md) | [(3.4)](/filings/0001834376-25-000003.md) | [(5.9)](/filings/0001834376-25-000010.md) | [(1.7) d](/filings/0001834376-25-000062.md) | [(4.9)](/filings/0001834376-25-000074.md) | [(13.2)](/filings/0001834376-26-000013.md) | [(11.4)](/filings/0001834376-26-000022.md) | [(0.8) d](/filings/0001834376-26-000049.md) | [8.0](/filings/0001834376-25-000074.md) | [10.6](/filings/0001834376-26-000013.md) | [(29.5)](/filings/0001834376-26-000022.md) | [8.3 d](/filings/0001834376-26-000049.md) |
| Diluted EPS | $ per share | [(0.08)](/filings/0001834376-24-000086.md) | [(0.03)](/filings/0001834376-25-000003.md) | [(0.04)](/filings/0001834376-25-000010.md) | not reported | [(0.04)](/filings/0001834376-25-000074.md) | [(0.10)](/filings/0001834376-26-000013.md) | [(0.08)](/filings/0001834376-26-000022.md) | not reported | [0.06](/filings/0001834376-25-000074.md) | [0.08](/filings/0001834376-26-000013.md) | [(0.22)](/filings/0001834376-26-000022.md) | not reported |
| Basic EPS | $ per share | [(0.08)](/filings/0001834376-24-000086.md) | [(0.03)](/filings/0001834376-25-000003.md) | [(0.04)](/filings/0001834376-25-000010.md) | not reported | [(0.04)](/filings/0001834376-25-000074.md) | [(0.10)](/filings/0001834376-26-000013.md) | [(0.08)](/filings/0001834376-26-000022.md) | not reported | [0.06](/filings/0001834376-25-000074.md) | [0.08](/filings/0001834376-26-000013.md) | [(0.22)](/filings/0001834376-26-000022.md) | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [88.4](/filings/0001834376-23-000027.md) | [54.1](/filings/0001834376-24-000008.md) | [54.1](/filings/0001834376-24-000022.md) | [56.9](/filings/0001834376-25-000062.md) | [39.0](/filings/0001834376-24-000086.md) | [46.1](/filings/0001834376-25-000003.md) | [60.5](/filings/0001834376-25-000010.md) | [64.1](/filings/0001834376-26-000049.md) | [67.1](/filings/0001834376-25-000074.md) | [83.2](/filings/0001834376-26-000013.md) | [95.5](/filings/0001834376-26-000022.md) | [97.9](/filings/0001834376-26-000049.md) |
| Current assets | $m | [196](/filings/0001834376-23-000027.md) | [157](/filings/0001834376-24-000008.md) | [153](/filings/0001834376-24-000022.md) | [173](/filings/0001834376-25-000062.md) | [159](/filings/0001834376-24-000086.md) | [168](/filings/0001834376-25-000003.md) | [176](/filings/0001834376-25-000010.md) | [176](/filings/0001834376-26-000049.md) | [162](/filings/0001834376-25-000074.md) | [182](/filings/0001834376-26-000013.md) | [203](/filings/0001834376-26-000022.md) | [214](/filings/0001834376-26-000049.md) |
| Total assets | $m | [546](/filings/0001834376-23-000027.md) | [534](/filings/0001834376-24-000008.md) | [527](/filings/0001834376-24-000022.md) | [548](/filings/0001834376-25-000062.md) | [528](/filings/0001834376-24-000086.md) | [525](/filings/0001834376-25-000003.md) | [537](/filings/0001834376-25-000010.md) | [527](/filings/0001834376-26-000049.md) | [510](/filings/0001834376-25-000074.md) | [527](/filings/0001834376-26-000013.md) | [547](/filings/0001834376-26-000022.md) | [557](/filings/0001834376-26-000049.md) |
| Current liabilities | $m | [139](/filings/0001834376-23-000027.md) | [123](/filings/0001834376-24-000008.md) | [122](/filings/0001834376-24-000022.md) | [139](/filings/0001834376-25-000062.md) | [131](/filings/0001834376-24-000086.md) | [145](/filings/0001834376-25-000003.md) | [225](/filings/0001834376-25-000010.md) | [165](/filings/0001834376-26-000049.md) | [138](/filings/0001834376-25-000074.md) | [145](/filings/0001834376-26-000013.md) | [196](/filings/0001834376-26-000022.md) | [204](/filings/0001834376-26-000049.md) |
| Total liabilities | $m | [241](/filings/0001834376-23-000027.md) | [231](/filings/0001834376-24-000008.md) | [229](/filings/0001834376-24-000022.md) | [248](/filings/0001834376-25-000062.md) | [237](/filings/0001834376-24-000086.md) | [247](/filings/0001834376-25-000003.md) | [269](/filings/0001834376-25-000010.md) | [264](/filings/0001834376-26-000049.md) | [234](/filings/0001834376-25-000074.md) | [239](/filings/0001834376-26-000013.md) | [289](/filings/0001834376-26-000022.md) | [289](/filings/0001834376-26-000049.md) |
| Long-term debt | $m | [64.0](/filings/0001834376-23-000027.md) | [63.2](/filings/0001834376-24-000008.md) | [62.3](/filings/0001834376-24-000022.md) | [61.5](/filings/0001834376-25-000062.md) | [60.6](/filings/0001834376-24-000086.md) | [59.8](/filings/0001834376-25-000003.md) | [1.8](/filings/0001834376-25-000010.md) | [57.5](/filings/0001834376-26-000049.md) | [56.2](/filings/0001834376-25-000074.md) | [56.0](/filings/0001834376-26-000013.md) | [55.4](/filings/0001834376-26-000022.md) | [45.5](/filings/0001834376-26-000049.md) |
| Current portion of debt | $m | [3.8](/filings/0001834376-23-000027.md) | [3.8](/filings/0001834376-24-000008.md) | [3.8](/filings/0001834376-24-000022.md) | [3.8](/filings/0001834376-25-000062.md) | [3.8](/filings/0001834376-24-000086.md) | [3.8](/filings/0001834376-25-000003.md) | [61.0](/filings/0001834376-25-000010.md) | [2.3](/filings/0001834376-26-000049.md) | [3.0](/filings/0001834376-25-000074.md) | [2.5](/filings/0001834376-26-000013.md) | [2.5](/filings/0001834376-26-000022.md) | [2.5](/filings/0001834376-26-000049.md) |
| Shareholders' equity | $m | [287](/filings/0001834376-23-000027.md) | [286](/filings/0001834376-24-000008.md) | [281](/filings/0001834376-24-000022.md) | [269](/filings/0001834376-25-000062.md) | [261](/filings/0001834376-24-000086.md) | [248](/filings/0001834376-25-000003.md) | [238](/filings/0001834376-25-000010.md) | [235](/filings/0001834376-26-000049.md) | [245](/filings/0001834376-25-000074.md) | [257](/filings/0001834376-26-000013.md) | [229](/filings/0001834376-26-000022.md) | [236](/filings/0001834376-26-000049.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(33.0)](/filings/0001834376-24-000086.md) | [(9.3) d](/filings/0001834376-25-000003.md) | [3.5 d](/filings/0001834376-25-000010.md) | [1.9 d](/filings/0001834376-25-000062.md) | [(7.5)](/filings/0001834376-25-000074.md) | [6.8 d](/filings/0001834376-26-000013.md) | [24.6 d](/filings/0001834376-26-000022.md) | [9.0 d](/filings/0001834376-26-000049.md) | [3.9](/filings/0001834376-25-000074.md) | [21.4 d](/filings/0001834376-26-000013.md) | [18.1 d](/filings/0001834376-26-000022.md) | [21.3 d](/filings/0001834376-26-000049.md) |
| Capital expenditure | $m | [2.6](/filings/0001834376-24-000086.md) | [1.6 d](/filings/0001834376-25-000003.md) | [0.5 d](/filings/0001834376-25-000010.md) | [3.3 d](/filings/0001834376-25-000062.md) | [2.2](/filings/0001834376-25-000074.md) | [1.3 d](/filings/0001834376-26-000013.md) | [2.9 d](/filings/0001834376-26-000022.md) | [(0.2) d](/filings/0001834376-26-000049.md) | [4.1](/filings/0001834376-25-000074.md) | [2.4 d](/filings/0001834376-26-000013.md) | [3.6 d](/filings/0001834376-26-000022.md) | [4.3 d](/filings/0001834376-26-000049.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: not reported

## Shares

| Line item | Unit | Q1 FY2023 (2022-09-30) | Q2 FY2023 (2022-12-31) | Q3 FY2023 (2023-03-31) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [136](/filings/0001834376-23-000027.md) | [136](/filings/0001834376-24-000008.md) | [136](/filings/0001834376-24-000022.md) | [136](/filings/0001834376-24-000086.md) | [136](/filings/0001834376-25-000003.md) | [136](/filings/0001834376-25-000010.md) | [136](/filings/0001834376-25-000074.md) | [135](/filings/0001834376-26-000013.md) | [135](/filings/0001834376-26-000022.md) | [137](/filings/0001834376-25-000074.md) | [136](/filings/0001834376-26-000013.md) | [136](/filings/0001834376-26-000022.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 136,451,425 at 2026-09-01, from the cover of the [10-K filed 2026-09-09](/filings/0001834376-26-000049.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.